Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

NCT04014166 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Thrombocytopenia
Mesenchymal Stem Cells

Interventions

OTHER: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)

Sponsor

Institute of Hematology & Blood Diseases Hospital, China